MCK vs RVP vs SKYA Stock Comparison

Mckesson, Retractable Technologies and SkyAI Prices as of Oct 28, 2026 Peers: Industry group
MCK Mckesson Corp
$960.80 +12.2% 1M +19.4% 1Y
Market cap
$112.02B
P/E
24.8x
Revenue (TTM)
$410.98B
Div. yield
0.35%
Drug Distribution Healthcare
8 wins
SKYA SkyAI, Inc.
$2.95 +66.7% 1M -42.7% 1Y
Market cap
$212.68M
P/E
–
Revenue (TTM)
$194.22K
Div. yield
–
Medical Supplies Healthcare
2 wins

Head to Head

10 decided of 12

Mckesson leads on 8 of the 12 questions below (Mckesson 8, SkyAI 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKRVPSKYALeader
Larger companyMarket capitalisation $112.02B $17.36M $212.68M MCK
Cheaper on earningsLower P/E, profitable companies only 24.8x -4.8x -0.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 20.4x — 0.0x SKYA
Faster revenue growthRevenue growth, trailing twelve months +8.8% -11.2% +108.9% SKYA
More profitableNet margin, trailing twelve months 1.1% -10.6% -158,431.4% MCK
Better return on capitalReturn on invested capital 107.9% -31.4% — MCK
Less leveragedLower net debt / EBITDA 0.6x 2.6x — MCK
Higher dividend yieldTrailing dividend yield 0.35% — — –
Better 1-year returnPrice return, last 12 months +19.4% -35.8% -42.7% MCK
Better 5-year returnAnnualised price return, 5 years +35.8%/yr -42.8%/yr — MCK
Less volatileAnnualised volatility, 1 year 30.7% 40.2% 105.9% MCK
Higher overall scoreMean of the five percentile scores vs peers 58/100 52/100 26/100 MCK

Percentile Scorecard

MCKRVPSKYA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKRVPSKYA
Valuation 50 #13 of 25 72 #65 of 227 2 #222 of 227
Growth 65 #9 of 24 34 #146 of 219 7 #204 of 219
Profitability 65 #9 of 24 40 #124 of 205 1 #203 of 205
Financial Health 48 #14 of 26 65 #84 of 237 95 #14 of 237
Shareholder Returns 60 #7 of 16 – –
Overall 58 52 26
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • RVP ranked among 247 companies in Medical Devices and Diagnostics
  • SKYA ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKRVPSKYASPY
1 month +12.2%-15.9%+66.7% +0.9%
3 months +8.1%-13.4%+115.3% +5.9%
6 months +16.8%-6.6%+68.6% +8.5%
Year to date +17.1%-24.9%+45.3% +13.3%
1 year +19.4%-35.8%-42.7% +12.4%
3 years +114.4%-45.3%-99.9% +88.1%
3 years, per year +29.0%-18.2%-90.0% +23.5%
5 years +362.2%-93.9%— +68.2%
5 years, per year +35.8%-42.8%— +11.0%
10 years +674.2%-76.8%— +263.4%
10 years, per year +22.7%-13.6%— +13.8%

Risk

MeasureMCKRVPSKYASPY
Volatility, 1Y 30.7%40.2%105.9% 12.7%
Downside volatility, 1Y 27.4%44.8%104.7% 12.7%
Beta vs S&P 500, 1Y -0.270.162.60 1.00
Return / volatility, 1Y 0.63-0.89-0.40 0.98
Max drawdown, 5Y -27.2%-94.0%-100.0% -25.4%
From 52-week high -6.7%-35.8%-42.7% -0.9%
52-week high $1,030.18$0.90$5.15 $779.14
52-week low $725.17$0.58$0.95 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKRVPSKYA
P/E now vs peer median 24.8xmedian 23.9x -4.8xmedian 28.8x -0.7xmedian 28.8x
P/S now vs peer median 0.3xmedian 0.3x 0.5xmedian 3.0x 1,095xmedian 3.0x
EV/EBITDA now vs peer median 16.1xmedian 12.7x 1.5xmedian 17.4x —median 17.4x
P/FCF now vs peer median 17.5xmedian 15.4x -3.4xmedian 25.7x —median 25.7x
P/B now vs peer median -26.4xmedian 2.5x 0.2xmedian 2.4x 1.4xmedian 2.4x
PEG now vs peer median 2.08median 1.34 0.22median 1.03 0.01median 1.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKRVPSKYA
Revenue $410.98B $33.90M $194.22K
Gross profit $14.96B -$491.51K $321.93K
Operating income $6.50B -$22.68M -$289.52M
Net income $5.30B -$3.37M -$307.71M
Free cash flow $6.42B -$5.11M –
R&D – $682.03K $399.91K
EPS (diluted) $38.52 $-0.12 $-4.27
Cash & equivalents $5.16B $2.64M $12.07M
Total debt $9.73B $3.40M –
Shares (diluted) 119.20M 29.94M 72.09M
Enterprise value $98.48B -$129.04M $171.38M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKRVPSKYA
P/E 24.8x -4.8x -0.7x
P/FCF 17.5x -3.4x –
P/Operating cash flow 16.3x -3.5x –
P/S 0.3x 0.5x 1,095x
P/B -26.4x 0.2x 1.4x
P/Tangible book -13.6x 0.2x 16.4x
EV/EBITDA 16.1x 1.5x –
EV/EBIT 18.0x 1.0x -0.7x
EV/Revenue 0.3x -0.6x 1,033x
EV/FCF 18.2x 4.3x –
EV/Operating cash flow 17.0x 4.4x –
PEG (3Y EPS CAGR) 2.08 0.22 0.01

Growth

14 metrics
MetricMCKRVPSKYA
Revenue growth (1Y) 8.8% -11.2% 108.9%
Revenue CAGR (3Y) 13.1% -14.7% 23.8%
Gross profit growth (1Y) 11.2% 81.2% –
Gross profit CAGR (3Y) 6.6% -26.8% –
Operating income growth (1Y) 46.6% -2.3% -5,525%
Operating income CAGR (3Y) 13.5% -11.7% -212.8%
Net income growth (1Y) 58.1% 61.4% -42,440%
Net income CAGR (3Y) 10.7% -23.9% -238.0%
EPS growth (1Y) 52.8% 59.8% -487.2%
EPS CAGR (3Y) 12.0% -21.9% -84.2%
Operating cash flow growth (1Y) 4.7% 58.8% –
Operating cash flow CAGR (3Y) 10.7% -16.8% –
Free cash flow growth (1Y) 6.8% 62.3% –
Free cash flow CAGR (3Y) 11.3% 20.0% –

Profitability

14 metrics
MetricMCKRVPSKYA
Gross margin 3.6% -1.4% 165.8%
EBITDA margin 1.8% -43.9% –
Operating margin 1.6% -66.9% -149,065%
Pretax margin 1.6% -9.9% -151,352%
Net margin 1.1% -10.6% -158,431%
FCF margin 1.6% -15.1% –
Operating cash flow margin 1.7% -14.6% –
Return on equity – -4.7% -140.2%
Return on assets 6.2% -2.4% -137.6%
Return on invested capital 107.9% -31.4% –
Return on capital employed 43.4% -18.0% -136.7%
Asset turnover 4.8x 0.2x 0.0x
Cash conversion (OCF / net income) 1.3x 1.5x –
Stock comp / revenue – – 48,037%

Financial Health

11 metrics
MetricMCKRVPSKYA
Debt / assets 11.0% 0.5% –
Debt / equity -2.3x 0.0x –
Net debt / EBITDA 0.6x 2.6x –
Debt / FCF 1.5x -0.1x –
Liabilities / assets 104.8% 48.6% 1.9%
Equity / assets -4.8% 51.4% 98.1%
Interest coverage 23.6x -278.8x –
Current ratio 0.9x 4.9x 5.3x
Quick ratio 0.5x 3.7x 4.4x
Cash ratio 0.1x 3.0x 4.2x
Altman Z-score 5.88 0.43 31.97

Shareholder Returns

7 metrics
MetricMCKRVPSKYA
Dividend yield 0.4% – –
Net buyback yield 5.9% – –
Shareholder yield 6.3% – –
Payout ratio (earnings) 7.4% – –
Payout ratio (FCF) 6.1% – –
Dividend growth (1Y) 11.3% – –
Dividend CAGR (3Y) 10.0% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKRVPSKYA
Forward P/E 20.4xFY2026 – 0.0xFY2026
EPS, next fiscal year $47.15FY2026 – $2,362.06FY2026
EPS growth, next FY +20.6%FY2026 – –
EPS growth, the year after +11.0% – –
Revenue, next fiscal year $444.47BFY2026 – $70.01MFY2026
Revenue growth, next FY +10.2%FY2026 – +34,200.1%FY2026
Revenue growth, the year after +1.5% – +17.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKRVPSKYA
Held by institutions 89.1% 8.8% –
Institutions holding 2,010 32 –
Change in shares held, QoQ -0.7% +5.9% –
Institutions buying 882 10 –
Institutions selling 791 4 –
Buyers to sellers 1.12 2.50 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKRVPSKYA
MCK 1.00 -0.16 -0.11
RVP -0.16 1.00 0.05
SKYA -0.11 0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, RVP and SKYA?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $112.02B, Retractable Technologies (RVP) $17.36M, SkyAI (SKYA) $212.68M.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.8%, Retractable Technologies (RVP) -11.2%, SkyAI (SKYA) +108.9%.

Which company is more profitable?

Mckesson (MCK) has the highest net margin (Mckesson (MCK) 1.1%, Retractable Technologies (RVP) -10.6%, SkyAI (SKYA) -158,431.4%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 107.9%, Retractable Technologies (RVP) -31.4%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Mckesson (MCK) +19.4%, Retractable Technologies (RVP) -35.8%, SkyAI (SKYA) -42.7%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +35.8%/yr, Retractable Technologies (RVP) -42.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Mckesson (MCK) 0.35%. Retractable Technologies (RVP) and SkyAI (SKYA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (Mckesson (MCK) 30.7%, Retractable Technologies (RVP) 40.2%, SkyAI (SKYA) 105.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, RVP and SKYA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.